Ron Holtz - 20 Mar 2023 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Chief Financial Officer
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Issuer symbol
MXCT
Transactions as of
20 Mar 2023
Transactions value $
$0
Form type
4
Filing time
21 Mar 2023, 16:46:44 UTC
Previous filing
29 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Award $0 +120K $0.00 120K 20 Mar 2023 Common Stock 120K $4.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.